New research recently published in the journal Emerging Infectious Diseases shows that the new MenB vaccine Bexsero (routinely offered to UK infants since September 2015) should provide additional protection against a particularly harmful strain of MenW (called ST-11). The MenW ST-11 strain has caused a year-on-year increase in cases of meningococcal disease (meningitis and septicaemia) in England since 2009 and is associated with severe illness and a higher death rate than other strains (13% fatality compared to 5-10%). Cases due to this strain nearly doubled from 2014 to 2015. Such was the concern about this rapid rise that the government introduced a programme in August 2015 (which is still ongoing throughout the UK) for teenagers from the age of 13-18 to be given a one off vaccine to protect them from the disease. In this latest research, scientists from Public Health England have used Meningitis Research Foundation’s open access Meningococcus Genome Library to...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




